Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-077971
Filing Date
2007-12-28
Accepted
2007-12-28 14:02:45
Documents
2
Period of Report
2007-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd185170.html 3  
1 FORM 3 rrd185170.xml 3 1523
2 POWER OF ATTORNEY rrd164516_185935.htm EX-24.1 3310
  Complete submission text file 0001181431-07-077971.txt   6685
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 41 SEYON STREET, BLDG#1 REPLIGEN WALTHAM MA 02453
Business Address 781-250-0111
Henry Earl Webb (Reporting) CIK: 0001421891 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 071331381